186 related articles for article (PubMed ID: 22185995)
1. Two cases of everolimus-associated interstitial pneumonia in patients with renal cell carcinoma.
Akata K; Yatera K; Ishimoto H; Kozaki M; Yamasaki K; Nagata S; Nishida C; Yoshida T; Kawanami T; Matsumoto T; Mukae H
Intern Med; 2011; 50(24):3013-7. PubMed ID: 22185995
[TBL] [Abstract][Full Text] [Related]
2. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
[TBL] [Abstract][Full Text] [Related]
3. Fatal case of cryptogenic organizing pneumonia associated with everolimus.
Nazer L; Alnajjar T; Salah S; Khzouz J; Alfaqeer N; Qandeel M
Ann Saudi Med; 2014; 34(5):437-9. PubMed ID: 25827702
[TBL] [Abstract][Full Text] [Related]
4. Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.
Mizuno R; Asano K; Mikami S; Nagata H; Kaneko G; Oya M
Jpn J Clin Oncol; 2012 May; 42(5):442-6. PubMed ID: 22438405
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib-related interstitial pneumonia after treatment with temsirolimus: a case of possible recall phenomenon.
Kushima H; Ishii H; Kadota J
Int J Urol; 2014 Apr; 21(4):420-1. PubMed ID: 24168290
[TBL] [Abstract][Full Text] [Related]
6. Adverse event profile and dose modification of everolimus for advanced renal cell carcinoma in real-world Japanese clinical practice.
Nozawa M; Nonomura N; Ueda T; Nishimura K; Kanayama HO; Miki T; Nakatani T; Tomita Y; Azuma H; Yoshioka T; Tsujihata M; Uemura H
Jpn J Clin Oncol; 2013 Nov; 43(11):1132-8. PubMed ID: 23999768
[TBL] [Abstract][Full Text] [Related]
7. Granuloma-forming interstitial pneumonia occurring one year after the start of everolimus therapy.
Saito Y; Kunugi S; Suzuki Y; Narita K; Miura Y; Minegishi Y; Kimura G; Kondo Y; Azuma A; Fukuda Y; Gemma A
Intern Med; 2013; 52(2):263-7. PubMed ID: 23318860
[TBL] [Abstract][Full Text] [Related]
8. [Rechallenge of everolimus for metastatic renal cell carcinoma after recovery from grade 3 interstitial lung disease: a case report].
Utsunomiya N; Kono Y; Matsumoto K; Matsumoto T; Nakagawa A; Tsunemori H; Okada T; Muguruma K; Kawakita M
Hinyokika Kiyo; 2014 Jan; 60(1):25-8. PubMed ID: 24594769
[TBL] [Abstract][Full Text] [Related]
9. Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.
White DA; Camus P; Endo M; Escudier B; Calvo E; Akaza H; Uemura H; Kpamegan E; Kay A; Robson M; Ravaud A; Motzer RJ
Am J Respir Crit Care Med; 2010 Aug; 182(3):396-403. PubMed ID: 20194812
[TBL] [Abstract][Full Text] [Related]
10. Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients.
Baas MC; Struijk GH; Moes DJ; van den Berk IA; Jonkers RE; de Fijter JW; van der Heide JJ; van Dijk M; ten Berge IJ; Bemelman FJ
Transpl Int; 2014 May; 27(5):428-36. PubMed ID: 24484452
[TBL] [Abstract][Full Text] [Related]
11. [Spontaneous Remission of Everolimus-Induced Interstitial Lung Disease in Metastatic Renal Cell Carcinoma : An Autopsy Case Report].
Kurokawa M; Naito S; Ichiyanagi O; Kabasawa T; Kurota Y; Sakurai T; Nishida H; Kawazoe H; Kato T; Nagaoka A; Yamakawa M; Tsuchiya N
Hinyokika Kiyo; 2017 Sep; 63(9):377-380. PubMed ID: 28992668
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1.
Tsukamoto T; Shinohara N; Tsuchiya N; Hamamoto Y; Maruoka M; Fujimoto H; Niwakawa M; Uemura H; Usami M; Terai A; Kanayama HO; Sumiyoshi Y; Eto M; Akaza H
Jpn J Clin Oncol; 2011 Jan; 41(1):17-24. PubMed ID: 20965941
[TBL] [Abstract][Full Text] [Related]
13. Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases.
Wong MK; Bjarnason GA; Hrushesky WJ; Webster P; Morava-Protzner I; Towers M
Cancer; 1995 May; 75(10):2558-64. PubMed ID: 7736401
[TBL] [Abstract][Full Text] [Related]
14. Severe everolimus-associated pneumonitis in a renal transplant recipient.
Alexandru S; Ortiz A; Baldovi S; Milicua JM; Ruíz-Escribano E; Egido J; Plaza JJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3353-5. PubMed ID: 18658177
[TBL] [Abstract][Full Text] [Related]
15. Patterns of pulmonary complications associated with sirolimus.
Chhajed PN; Dickenmann M; Bubendorf L; Mayr M; Steiger J; Tamm M
Respiration; 2006; 73(3):367-74. PubMed ID: 16127266
[TBL] [Abstract][Full Text] [Related]
16. Noninfectious pneumonitis in a patient with renal cell carcinoma treated with everolimus.
Creel P; Moldawer NP
Oncol Nurs Forum; 2011 Mar; 38(2):125-8. PubMed ID: 21356651
[No Abstract] [Full Text] [Related]
17. [A case of renal cell carcinoma complicated with interstitial pneumonitis, complete A-V block and pleural effusion during interferon-alpha therapy].
Tsushima K; Yamaguchi S; Furihata K; Hotta J; Sasabayashi M; Urushihata K; Takashi S; Tsukadaira A; Yamazaki Y; Satou E; Hanaoka M; Koizumi T; Fujimoto K; Ohkubo Y; Kubo K
Nihon Kokyuki Gakkai Zasshi; 2001 Nov; 39(11):893-8. PubMed ID: 11855092
[TBL] [Abstract][Full Text] [Related]
18. Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001).
White DA; Schwartz LH; Dimitrijevic S; Scala LD; Hayes W; Gross SH
J Thorac Oncol; 2009 Nov; 4(11):1357-63. PubMed ID: 19745764
[TBL] [Abstract][Full Text] [Related]
19. Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus.
Cetin B; Coskun U; Yildiz R; Buyukberber S; Baykara M; Benekli M
J Oncol Pharm Pract; 2011 Sep; 17(3):274-8. PubMed ID: 20215482
[TBL] [Abstract][Full Text] [Related]
20. Reversible sirolimus-associated pneumonitis after heart transplantation.
Hamour IM; Mittal TK; Bell AD; Banner NR
J Heart Lung Transplant; 2006 Feb; 25(2):241-4. PubMed ID: 16446228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
